|
Volumn 53, Issue 3, 2009, Pages 286-287
|
Treating refractory scleritis with infliximab
|
Author keywords
Infliximab; Scleritis; Tumor necrosis factor
|
Indexed keywords
ALKYLOXAN;
CIPOL N;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREDNISOLONE;
STEROID;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ADULT;
AGED;
AMNION;
AUTOIMMUNE DISEASE;
CASE REPORT;
CHOROID DETACHMENT;
CLINICAL FEATURE;
DISEASE COURSE;
DRUG EFFICACY;
EYE PAIN;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
MALE;
PRIORITY JOURNAL;
REPEATED DRUG DOSE;
RETINA DETACHMENT;
SCLERITIS;
STEROID THERAPY;
TISSUE TRANSPLANTATION;
TREATMENT OUTCOME;
VISUAL ACUITY;
AGED;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
RETINAL DETACHMENT;
RETROSPECTIVE STUDIES;
SCLERITIS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 66749169278
PISSN: 00215155
EISSN: None
Source Type: Journal
DOI: 10.1007/s10384-008-0652-5 Document Type: Letter |
Times cited : (21)
|
References (4)
|